RELMADA THERAPEUTICS CFO Shenouda Maged bought 200,000 shares at $4.20 to $4.25 across two transactions. His post-transaction holding was 1,000,000 shares, making the purchase 20% of that disclosed position for investors assessing insider ownership.

Key Highlights

  • Both transactions carried SEC transaction code P, indicating open-market purchases.
  • Shenouda Maged bought 200,000 RELMADA THERAPEUTICS shares across two transactions.
  • Following the transactions, Maged reported ownership of 1,000,000 shares.

His reported ownership following the purchases stood at 1,000,000 shares. Both entries used transaction code P. The purchases were attributed to Maged in his role as RELMADA THERAPEUTICS (NASDAQ: RLMD)’ chief financial officer. The reported 1,000,000-share position is the holding stated after both transactions.

Two Purchases Span September 9 and 10

The filing reported two separate transactions between September 9 and September 10. Each transaction used the same P classification. Transaction code P denotes an open-market or private purchase.